Chemexpress(SH:688131)2025-02-27 10:40Financial Performance - The company achieved total operating revenue of CNY 2,257,731,970.76, representing a year-on-year increase of 20.09%[4] - Operating profit reached CNY 253,368,212.98, a significant increase of 97.44% compared to the previous year[4] - Net profit attributable to shareholders of the parent company was CNY 204,979,356.42, up 60.83% year-on-year[4] - The net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was CNY 172,610,338.19, reflecting a growth of 56.74%[4] - Basic earnings per share increased to CNY 0.97, a rise of 59.02% from the previous year[4] Assets and Equity - Total assets at the end of the reporting period were CNY 5,557,885,780.88, up 32.58% from the beginning of the period[5] - Shareholders' equity attributable to the parent company increased to CNY 2,883,336,643.19, a growth of 14.92%[5] Operational Efficiency - The company focused on enhancing operational efficiency and cost control, contributing to improved financial performance[9] Business Growth - The strong growth in the high-margin life science reagent business significantly boosted overall net profit[10] Capital Management - The company implemented a capital reserve conversion to increase share capital, resulting in a 40.28% increase in share capital[10]